Patents by Inventor Barbara Briggs

Barbara Briggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066443
    Abstract: Devices and methods for filtering, drying, and mechanically processing active pharmaceutical ingredients are generally described.
    Type: Application
    Filed: September 1, 2023
    Publication date: February 29, 2024
    Applicant: Massachusetts Institute of Technology
    Inventors: David Brancazio, Allan S. Myerson, Mohammad A. Azad, Gregory J. Hammersmith, Gerard Capellades Mendez, Clemence Neurohr, Kersten Rapp, Naomi Elizabeth Barbara Briggs
  • Patent number: 11911719
    Abstract: Devices and methods for filtering, drying, and mechanically processing active pharmaceutical ingredients are generally described.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: February 27, 2024
    Assignee: Massachusetts Institute of Technology
    Inventors: David Brancazio, Allan S. Myerson, Mohammad A. Azad, Gregory J. Hammersmith, Gerard Capellades Mendez, Clemence Neurohr, Kersten Rapp, Naomi Elizabeth Barbara Briggs
  • Patent number: 11786846
    Abstract: Devices and methods for filtering, drying, and mechanically processing active pharmaceutical ingredients are generally described.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: October 17, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: David Brancazio, Allan S. Myerson, Mohammad A. Azad, Gregory J. Hammersmith, Gerard Capellades Mendez, Clemence Neurohr, Kersten Rapp, Naomi Elizabeth Barbara Briggs
  • Patent number: 6756403
    Abstract: Disclosed are process steps and novel processes for producing chromane compositions enriched in at least one (2R or 2S) enantiomer, preferably chroman-2-yl carboxylic acid compounds and chroman-2-yl carboxylic acid esters which are intermediates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are enzymatic processes for resolving chiral intermediates or final products to provide desired enantiomers.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: June 29, 2004
    Assignee: Eli Lilly and Company
    Inventors: Barbara Briggs, James Kanter, John J. G. Mullins, Gerd Ruhter, Uko Udodong, Milton Zmijewski, Jr., Daniel Verral, II
  • Publication number: 20040053992
    Abstract: Disclosed are process steps and novel processes for producing chromane compositions enriched in at least one (2R or 2S) enantiomer, preferably chroman-2-yl carboxylic acid compounds and chroman-2-yl carboxylic acid esters which are intermediates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are enzymatic processes for resolving chiral intermediates or final products to provide desired enantiomers.
    Type: Application
    Filed: July 11, 2003
    Publication date: March 18, 2004
    Inventors: Barbara Briggs, James Kanter, John J.G. Mullins, Gerd Ruhter, Uko Udodong, Milton Zmijewski Jr., Daniel Verral II
  • Patent number: 6610687
    Abstract: The invention relates to benzofuranylsulfonates of the general formula (I), their preparation and their use for the treatment of inflammation.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: August 26, 2003
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gabriele Bräunlich, Mazen Es-Sayed, Rüdiger Fischer, Burkhard Fugmann, Rolf Henning, Stephan Schneider, Michael Sperzel, Karl-Heinz Schlemmer, Graham Sturton, Mary F. Fitzgerald, Barbara Briggs, Arnel Concepcion, William Bullock
  • Patent number: 6169092
    Abstract: 3-Urea-pyridofurans and -pyridothiophenes are prepared by reacting appropriately substituted 3-amino-pyridofurans or -pyridothiophenes with isocyanates or isothiocyanates. The 3-urea-pyridofurans and -pyridothiophenes can be used as active ingredients in medicaments, particularly in medicaments for the treatment of acute and chronic inflammatory processes.
    Type: Grant
    Filed: January 5, 1999
    Date of Patent: January 2, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Gabriele Br{umlaut over (a)}unlich, Mazen Es-Sayed, R{umlaut over (u)}diger Fischer, Rolf Henning, Burkhard Fugmann, Stephan Schneider, Michael Sperzel, Graham Sturton, Mary Fitzgerald, Barbara Briggs, Arnel Concepcion